{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T06:14:49Z","timestamp":1774332889684,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T00:00:00Z","timestamp":1729555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T00:00:00Z","timestamp":1729555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Jin Yang","award":["2023YFQ0101"],"award-info":[{"award-number":["2023YFQ0101"]}]},{"name":"Jin Yang","award":["2023YFQ0101"],"award-info":[{"award-number":["2023YFQ0101"]}]},{"name":"Jin Yang","award":["2023YFQ0101"],"award-info":[{"award-number":["2023YFQ0101"]}]},{"name":"Jin Yang","award":["2023YFQ0101"],"award-info":[{"award-number":["2023YFQ0101"]}]},{"name":"Jin Yang","award":["2023YFQ0101"],"award-info":[{"award-number":["2023YFQ0101"]}]},{"name":"Yaling Li","award":["2022YFS0625"],"award-info":[{"award-number":["2022YFS0625"]}]},{"name":"Yaling Li","award":["2022YFS0625"],"award-info":[{"award-number":["2022YFS0625"]}]},{"name":"Yaling Li","award":["2022YFS0625"],"award-info":[{"award-number":["2022YFS0625"]}]},{"name":"Yaling Li","award":["2022YFS0625"],"award-info":[{"award-number":["2022YFS0625"]}]},{"name":"Yaling Li","award":["2022YFS0625"],"award-info":[{"award-number":["2022YFS0625"]}]},{"name":"Xiaoli Yang","award":["2022-SYF-55"],"award-info":[{"award-number":["2022-SYF-55"]}]},{"name":"Xiaoli Yang","award":["2022-SYF-55"],"award-info":[{"award-number":["2022-SYF-55"]}]},{"name":"Xiaoli Yang","award":["2022-SYF-55"],"award-info":[{"award-number":["2022-SYF-55"]}]},{"name":"Xiaoli Yang","award":["2022-SYF-55"],"award-info":[{"award-number":["2022-SYF-55"]}]},{"name":"Xiaoli Yang","award":["2022-SYF-55"],"award-info":[{"award-number":["2022-SYF-55"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"DOI":"10.1007\/s00432-024-05960-7","type":"journal-article","created":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T05:03:30Z","timestamp":1729573410000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association between antithrombotic agents use and hepatocellular carcinoma risk: a two-sample mendelian randomization analysis"],"prefix":"10.1007","volume":"150","author":[{"given":"Fengyi","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ouyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjian","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaqi","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoli","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,22]]},"reference":[{"issue":"4","key":"5960_CR34","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/jrsm.1346","volume":"10","author":"J Bowden","year":"2019","unstructured":"Bowden J, Holmes MV (2019) Meta-analysis and mendelian randomization: a review. Res Synth Methods 10(4):486\u2013496. https:\/\/doi.org\/10.1002\/jrsm.1346","journal-title":"Res Synth Methods"},{"issue":"2","key":"5960_CR28","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden J, Davey Smith G, Burgess S (2015) Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol 44(2):512\u2013525. https:\/\/doi.org\/10.1093\/ije\/dyv080","journal-title":"Int J Epidemiol"},{"issue":"5","key":"5960_CR33","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","volume":"32","author":"S Burgess","year":"2017","unstructured":"Burgess S, Thompson SG (2017) Interpreting findings from mendelian randomization using the MR-Egger method [published correction appears in. Eur J Epidemiol 2017;:] Eur J Epidemiol 32(5):377\u2013389. https:\/\/doi.org\/10.1007\/s10654-017-0255-x","journal-title":"Eur J Epidemiol 2017;:] Eur J Epidemiol"},{"key":"5960_CR18","doi-asserted-by":"publisher","unstructured":"Burgess S, Butterworth A, Malarstig A, Thompson SG (2012) Use of mendelian randomisation to assess potential benefit of clinical intervention. BMJ 345:e7325. https:\/\/doi.org\/10.1136\/bmj.e7325","DOI":"10.1136\/bmj.e7325"},{"issue":"7","key":"5960_CR27","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/gepi.21758","volume":"37","author":"S Burgess","year":"2013","unstructured":"Burgess S, Butterworth A, Thompson SG (2013) Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol 37(7):658\u2013665. https:\/\/doi.org\/10.1002\/gepi.21758","journal-title":"Genet Epidemiol"},{"issue":"2","key":"5960_CR17","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1093\/ije\/dyu176","volume":"44","author":"S Burgess","year":"2015","unstructured":"Burgess S, Daniel RM, Butterworth AS, Thompson SG, EPIC-InterAct Consortium (2015) Network mendelian randomization: using genetic variants as instrumental variables to investigate mediation in causal pathways. Int J Epidemiol 44(2):484\u2013495. https:\/\/doi.org\/10.1093\/ije\/dyu176","journal-title":"Int J Epidemiol"},{"key":"5960_CR29","doi-asserted-by":"publisher","first-page":"186","DOI":"10.12688\/wellcomeopenres.15555.3","volume":"4","author":"S Burgess","year":"2023","unstructured":"Burgess S, Davey Smith G, Davies NM et al (2023) Guidelines for performing mendelian randomization investigations: update for summer 2023. Wellcome Open Res 4:186. https:\/\/doi.org\/10.12688\/wellcomeopenres.15555.3","journal-title":"Wellcome Open Res"},{"issue":"5","key":"5960_CR45","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1038\/ajg.2010.475","volume":"106","author":"HF Chiu","year":"2011","unstructured":"Chiu HF, Ho SC, Chen CC, Yang CY (2011) Statin use and the risk of liver cancer: a population-based case\u2013control study. Am J Gastroenterol 106(5):894\u2013898. https:\/\/doi.org\/10.1038\/ajg.2010.475","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"5960_CR31","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1038\/s41467-020-14452-4","volume":"11","author":"Y Cho","year":"2020","unstructured":"Cho Y, Haycock PC, Sanderson E et al (2020) Exploiting horizontal pleiotropy to search for causal pathways within a mendelian randomization framework. Nat Commun 11(1):1010 Published 2020 Feb 21. https:\/\/doi.org\/10.1038\/s41467-020-14452-4","journal-title":"Nat Commun"},{"key":"5960_CR23","doi-asserted-by":"publisher","first-page":"763538","DOI":"10.3389\/fendo.2021.763538","volume":"12","author":"Z Cui","year":"2021","unstructured":"Cui Z, Feng H, He B, He J, Tian Y (2021) Relationship between serum amino acid levels and bone Mineral density: a mendelian randomization study. Front Endocrinol (Lausanne) 12:763538 Published 2021 Nov 9. https:\/\/doi.org\/10.3389\/fendo.2021.763538","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5960_CR20","doi-asserted-by":"publisher","unstructured":"Davies NM, Holmes MV, Davey Smith G (2018) Reading mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ 362(k601). https:\/\/doi.org\/10.1136\/bmj.k601. Published 2018 Jul 12","DOI":"10.1136\/bmj.k601"},{"issue":"11","key":"5960_CR9","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1001\/2012.jama.10717","volume":"308","author":"JJ DiNicolantonio","year":"2012","unstructured":"DiNicolantonio JJ, O\u2019Keefe JH, Lavie CJ (2012) Benefits and risks of aspirin use. JAMA 308(11):1088\u20131090. https:\/\/doi.org\/10.1001\/2012.jama.10717","journal-title":"JAMA"},{"key":"5960_CR10","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1146\/annurev-med-060319-120913","volume":"72","author":"DA Drew","year":"2021","unstructured":"Drew DA, Chan AT (2021) Aspirin in the Prevention of Colorectal Neoplasia. Annu Rev Med 72:415\u2013430. https:\/\/doi.org\/10.1146\/annurev-med-060319-120913","journal-title":"Annu Rev Med"},{"key":"5960_CR3","doi-asserted-by":"publisher","unstructured":"Fitzmaurice C, Abate D et al (2021) Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study [published correction appears in JAMA Oncol. 2020;6(3):444] [published correction appears in JAMA Oncol. 2020;6(5):789] [published correction appears in JAMA Oncol. 2021;7(3):466]. JAMA Oncol. 2019;5(12):1749\u20131768. https:\/\/doi.org\/10.1001\/jamaoncol.2019.2996","DOI":"10.1001\/jamaoncol.2019.2996"},{"issue":"1","key":"5960_CR7","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/hep.29086","volume":"67","author":"JK Heimbach","year":"2018","unstructured":"Heimbach JK, Kulik LM, Finn RS et al (2018) AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology 67(1):358\u2013380. https:\/\/doi.org\/10.1002\/hep.29086","journal-title":"Hepatology"},{"key":"5960_CR30","doi-asserted-by":"publisher","first-page":"e34408","DOI":"10.7554\/eLife.34408","volume":"7","author":"G Hemani","year":"2018","unstructured":"Hemani G, Zheng J, Elsworth B et al (2018) The MR-Base platform supports systematic causal inference across the human phenome. Elife 7:e34408. https:\/\/doi.org\/10.7554\/eLife.34408. Published 2018 May 30","journal-title":"Elife"},{"key":"5960_CR42","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ejphar.2018.01.031","volume":"823","author":"Z Huang","year":"2018","unstructured":"Huang Z, Fang W, Liu W et al (2018) Aspirin induces beclin-1-dependent autophagy of human hepatocellular carcinoma cell. Eur J Pharmacol 823:58\u201364. https:\/\/doi.org\/10.1016\/j.ejphar.2018.01.031","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"5960_CR38","doi-asserted-by":"publisher","first-page":"4968","DOI":"10.1038\/s41598-018-23343-0","volume":"8","author":"IC Hwang","year":"2018","unstructured":"Hwang IC, Chang J, Kim K, Park SM (2018) Aspirin use and risk of Hepatocellular Carcinoma in a National Cohort Study of Korean adults. Sci Rep 8(1):4968. https:\/\/doi.org\/10.1038\/s41598-018-23343-0","journal-title":"Sci Rep"},{"issue":"11","key":"5960_CR12","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1038\/nm1317","volume":"11","author":"M Iannacone","year":"2005","unstructured":"Iannacone M, Sitia G, Isogawa M et al (2005) Platelets mediate cytotoxic T lymphocyte-induced liver damage. Nat Med 11(11):1167\u20131169. https:\/\/doi.org\/10.1038\/nm1317","journal-title":"Nat Med"},{"issue":"22","key":"5960_CR25","doi-asserted-by":"publisher","first-page":"4851","DOI":"10.1093\/bioinformatics\/btz469","volume":"35","author":"MA Kamat","year":"2019","unstructured":"Kamat MA, Blackshaw JA, Young R et al (2019) PhenoScanner V2: an expanded tool for searching human genotype-phenotype associations. Bioinformatics 35(22):4851\u20134853. https:\/\/doi.org\/10.1093\/bioinformatics\/btz469","journal-title":"Bioinformatics"},{"key":"5960_CR47","doi-asserted-by":"publisher","unstructured":"Kim G, Jang SY, Han E et al (2017) Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case-control study. Int J Cancer. 2017;140(4):798\u2013806. https:\/\/doi.org\/10.1002\/ijc.30506","DOI":"10.1002\/ijc.30506"},{"issue":"1","key":"5960_CR11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/2045-3701-1-5","volume":"1","author":"M Kumar","year":"2011","unstructured":"Kumar M, Zhao X, Wang XW (2011) Molecular carcinogenesis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: one step closer to personalized medicine? Cell Biosci 1(1):5. https:\/\/doi.org\/10.1186\/2045-3701-1-5. Published 2011 Jan 24","journal-title":"Cell Biosci"},{"issue":"2","key":"5960_CR24","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41588-020-00763-1","volume":"53","author":"A Kurilshikov","year":"2021","unstructured":"Kurilshikov A, Medina-Gomez C, Bacigalupe R et al (2021) Large-scale association analyses identify host factors influencing human gut microbiome composition. Nat Genet 53(2):156\u2013165. https:\/\/doi.org\/10.1038\/s41588-020-00763-1","journal-title":"Nat Genet"},{"issue":"5","key":"5960_CR41","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1001\/jamainternmed.2018.8342","volume":"179","author":"TY Lee","year":"2019","unstructured":"Lee TY, Hsu YC, Tseng HC et al (2019) Association of Daily Aspirin Therapy with Risk of Hepatocellular Carcinoma in patients with chronic Hepatitis B. JAMA Intern Med 179(5):633\u2013640. https:\/\/doi.org\/10.1001\/jamainternmed.2018.8342","journal-title":"JAMA Intern Med"},{"issue":"1","key":"5960_CR39","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12876-020-1158-y","volume":"20","author":"YH Liao","year":"2020","unstructured":"Liao YH, Hsu RJ, Wang TH et al (2020) Aspirin decreases hepatocellular carcinoma risk in hepatitis C virus carriers: a nationwide cohort study. BMC Gastroenterol 20(1):6. https:\/\/doi.org\/10.1186\/s12876-020-1158-y. Published 2020 Jan 9","journal-title":"BMC Gastroenterol"},{"issue":"32","key":"5960_CR13","doi-asserted-by":"publisher","first-page":"12840","DOI":"10.1073\/pnas.1210296109","volume":"109","author":"MK Maini","year":"2012","unstructured":"Maini MK, Schurich A (2012) Platelets harness the immune response to drive liver cancer. Proc Natl Acad Sci U S A 109(32):12840\u201312841. https:\/\/doi.org\/10.1073\/pnas.1210296109","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"5960_CR8","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/hep.29913","volume":"68","author":"JA Marrero","year":"2018","unstructured":"Marrero JA, Kulik LM, Sirlin CB et al (2018) Diagnosis, staging, and management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the study of Liver diseases. Hepatology 68(2):723\u2013750. https:\/\/doi.org\/10.1002\/hep.29913","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"5960_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/hep.31288","volume":"1","author":"KA McGlynn","year":"2021","unstructured":"McGlynn KA, Petrick JL, El-Serag HB (2021) Epidemiology of Hepatocellular Carcinoma. Hepatol 73 Suppl 1(Suppl 1):4\u201313. https:\/\/doi.org\/10.1002\/hep.31288","journal-title":"Hepatol 73 Suppl"},{"key":"5960_CR48","doi-asserted-by":"publisher","first-page":"4645","DOI":"10.2147\/OTT.S143154","volume":"10","author":"Q Pang","year":"2017","unstructured":"Pang Q, Jin H, Qu K et al (2017) The effects of nonsteroidal anti-inflammatory drugs in the incident and recurrent risk of hepatocellular carcinoma: a meta-analysis. Onco Targets Ther 10:4645\u20134656 Published 2017 Sep 20. https:\/\/doi.org\/10.2147\/OTT.S143154","journal-title":"Onco Targets Ther"},{"issue":"7","key":"5960_CR14","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.3390\/cancers11071022","volume":"11","author":"N Pavlovic","year":"2019","unstructured":"Pavlovic N, Rani B, Gerwins P, Heindryckx F (2019) Platelets as key factors in Hepatocellular Carcinoma. Cancers (Basel) 11(7):1022. https:\/\/doi.org\/10.3390\/cancers11071022. Published 2019 Jul 20","journal-title":"Cancers (Basel)"},{"key":"5960_CR36","doi-asserted-by":"publisher","unstructured":"Petrick JL, Sahasrabuddhe VV, Chan AT, Alavanja MC, Beane-Freeman LE, Buring JE, Chen J, Chong DQ, Freedman ND, Fuchs CS, Gaziano JM, Giovannucci E, Graubard BI, Hollenbeck AR, Hou L, Jacobs EJ, King LY, Koshiol J, Lee IM, Linet MS, McGlynn KA (2015) NSAID Use and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: the Liver Cancer Pooling Project. Cancer prevention research (Philadelphia, Pa. 8(12):1156\u20131162. https:\/\/doi.org\/10.1158\/1940-6207.CAPR-15-0126","DOI":"10.1158\/1940-6207.CAPR-15-0126"},{"issue":"23","key":"5960_CR35","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1093\/jnci\/djs452","volume":"104","author":"VV Sahasrabuddhe","year":"2012","unstructured":"Sahasrabuddhe VV, Gunja MZ, Graubard BI et al (2012) Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma. J Natl Cancer Inst 104(23):1808\u20131814. https:\/\/doi.org\/10.1093\/jnci\/djs452","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"5960_CR22","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/s41588-019-0350-x","volume":"51","author":"S Sanna","year":"2019","unstructured":"Sanna S, van Zuydam NR, Mahajan A et al (2019) Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases. Nat Genet 51(4):600\u2013605. https:\/\/doi.org\/10.1038\/s41588-019-0350-x","journal-title":"Nat Genet"},{"key":"5960_CR5","doi-asserted-by":"publisher","first-page":"e2200118","DOI":"10.1200\/GO.22.00118","volume":"8","author":"VV Shetty","year":"2022","unstructured":"Shetty VV, Kellarai A (2022) Comprehensive Review of Hepatocellular Carcinoma in India: current challenges and future directions. JCO Glob Oncol 8:e2200118. https:\/\/doi.org\/10.1200\/GO.22.00118","journal-title":"JCO Glob Oncol"},{"issue":"2","key":"5960_CR43","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3892\/or.2020.7630","volume":"44","author":"T Shi","year":"2020","unstructured":"Shi T, Fujita K, Gong J et al (2020) Aspirin inhibits hepatocellular carcinoma cell proliferation in vitro and in vivo via inducing cell cycle arrest and apoptosis. Oncol Rep 44(2):457\u2013468. https:\/\/doi.org\/10.3892\/or.2020.7630","journal-title":"Oncol Rep"},{"issue":"9","key":"5960_CR40","doi-asserted-by":"publisher","first-page":"e19008","DOI":"10.1097\/MD.0000000000019008","volume":"99","author":"S Shin","year":"2020","unstructured":"Shin S, Lee SH, Lee M et al (2020) Aspirin and the risk of hepatocellular carcinoma development in patients with alcoholic cirrhosis. Med (Baltim) 99(9):e19008. https:\/\/doi.org\/10.1097\/MD.0000000000019008","journal-title":"Med (Baltim)"},{"key":"5960_CR6","doi-asserted-by":"publisher","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A (2021) Cancer Statistics, CA Cancer J Clin. 2021;71(1):7\u201333. https:\/\/doi.org\/10.3322\/caac.21654","DOI":"10.3322\/caac.21654"},{"issue":"12","key":"5960_CR37","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1001\/jamaoncol.2018.4154","volume":"4","author":"TG Simon","year":"2018","unstructured":"Simon TG, Ma Y, Ludvigsson JF, Chong DQ, Giovannucci EL, Fuchs CS, Meyerhardt JA, Corey KE, Chung RT, Zhang X, Chan AT (2018) Association between Aspirin Use and Risk of Hepatocellular Carcinoma. JAMA Oncol 4(12):1683\u20131690. https:\/\/doi.org\/10.1001\/jamaoncol.2018.4154","journal-title":"JAMA Oncol"},{"issue":"2","key":"5960_CR2","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.jhep.2019.08.025","volume":"72","author":"AG Singal","year":"2020","unstructured":"Singal AG, Lampertico P, Nahon P (2020) Epidemiology and surveillance for hepatocellular carcinoma: new trends. J Hepatol 72(2):250\u2013261. https:\/\/doi.org\/10.1016\/j.jhep.2019.08.025","journal-title":"J Hepatol"},{"issue":"4","key":"5960_CR21","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/gepi.22295","volume":"44","author":"EAW Slob","year":"2020","unstructured":"Slob EAW, Burgess S (2020) A comparison of robust mendelian randomization methods using summary data. Genet Epidemiol 44(4):313\u2013329. https:\/\/doi.org\/10.1002\/gepi.22295","journal-title":"Genet Epidemiol"},{"issue":"1","key":"5960_CR19","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1093\/ije\/dyh132","volume":"33","author":"GD Smith","year":"2004","unstructured":"Smith GD, Ebrahim S (2004) Mendelian randomization: prospects, potentials, and limitations. Int J Epidemiol 33(1):30\u201342. https:\/\/doi.org\/10.1093\/ije\/dyh132","journal-title":"Int J Epidemiol"},{"key":"5960_CR46","doi-asserted-by":"publisher","unstructured":"Tsan YT, Lee CH, Wang JD, Chen PC (2012) Statins and the risk of hepatocellular carcinoma in patients with hepatitis B virus infection [published correction appears in J Clin Oncol. 2013;31(24):3049]. J Clin Oncol. 30(6):623\u2013630. https:\/\/doi.org\/10.1200\/JCO.2011.36.0917","DOI":"10.1200\/JCO.2011.36.0917"},{"issue":"15","key":"5960_CR4","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1056\/NEJMra1713263","volume":"380","author":"A Villanueva","year":"2019","unstructured":"Villanueva A (2019) Hepatocellular Carcinoma. N Engl J Med 380(15):1450\u20131462. https:\/\/doi.org\/10.1056\/NEJMra1713263","journal-title":"N Engl J Med"},{"issue":"10360","key":"5960_CR26","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","volume":"400","author":"A Vogel","year":"2022","unstructured":"Vogel A, Meyer T, Sapisochin G, Salem R, Saborowski A (2022) Hepatocellular carcinoma. Lancet 400(10360):1345\u20131362. https:\/\/doi.org\/10.1016\/S0140-6736(22)01200-4","journal-title":"Lancet"},{"key":"5960_CR32","doi-asserted-by":"publisher","first-page":"113","DOI":"10.12688\/wellcomeopenres.15334.2","volume":"4","author":"VM Walker","year":"2019","unstructured":"Walker VM, Davies NM, Hemani G et al (2019) Using the MR-Base platform to investigate risk factors and drug targets for thousands of phenotypes. Wellcome Open Res 4:113 Published 2019 Nov 7. https:\/\/doi.org\/10.12688\/wellcomeopenres.15334.2","journal-title":"Wellcome Open Res"},{"key":"5960_CR44","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.ebiom.2019.06.048","volume":"45","author":"T Wang","year":"2019","unstructured":"Wang T, Fu X, Jin T et al (2019) Aspirin targets P4HA2 through inhibiting NF-\u03baB and LMCD1-AS1\/let-7\u00a0g to inhibit tumour growth and collagen deposition in hepatocellular carcinoma. EBioMedicine 45:168\u2013180. https:\/\/doi.org\/10.1016\/j.ebiom.2019.06.048","journal-title":"EBioMedicine"},{"issue":"1","key":"5960_CR16","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1038\/s41467-019-09572-5","volume":"10","author":"Y Wu","year":"2019","unstructured":"Wu Y, Byrne EM, Zheng Z et al (2019) Genome-wide association study of medication-use and associated disease in the UK Biobank. Nat Commun 10(1):1891 Published 2019 Apr 23. https:\/\/doi.org\/10.1038\/s41467-019-09572-5","journal-title":"Nat Commun"},{"issue":"6","key":"5960_CR15","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1111\/apt.17371","volume":"57","author":"RW Zeng","year":"2023","unstructured":"Zeng RW, Yong JN, Tan DJH et al (2023) Meta-analysis: chemoprevention of hepatocellular carcinoma with statins, aspirin and metformin. Aliment Pharmacol Ther 57(6):600\u2013609. https:\/\/doi.org\/10.1111\/apt.17371","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-024-05960-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-024-05960-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-024-05960-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T08:06:01Z","timestamp":1730793961000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-024-05960-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,22]]},"references-count":48,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["5960"],"URL":"https:\/\/doi.org\/10.1007\/s00432-024-05960-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4608895\/v1","asserted-by":"object"}]},"ISSN":["1432-1335"],"issn-type":[{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,22]]},"assertion":[{"value":"20 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All authors have no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"470"}}